Researchers have discovered that the common antibiotic erythromycin may have potential as a treatment for myotonic dystrophy, a genetic neuromuscular disorder. This finding opens up new possibilities for treating this debilitating condition. The antibiotic works by targeting the RNA in the cells, which is misregulated in individuals with myotonic dystrophy. This discovery could lead to the development of new therapies for this condition, which currently has no cure. However, further research is needed to fully understand the potential benefits of erythromycin in treating myotonic dystrophy.
Source link
Use of common antibiotic erythromycin potential cure for myotonic dystrophy
